1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Roles	_	_	NNS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	Bacterial	_	_	JJ	_	_	_	_	_
4	Virulence	_	_	NN	_	_	_	_	_
5	Factors	_	_	NNS	_	_	_	_	_
6	During	_	_	IN	_	_	_	_	_
7	Invasion	_	_	NN	_	_	_	_	_


1	Through	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	Barriers	_	_	NNP	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	CNS	_	_	NNP	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	be	_	_	VB	_	_	_	_	_
3	able	_	_	JJ	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	enter	_	_	VB	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	CNS	_	_	NNP	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	bacterial	_	_	JJ	_	_	_	_	_
10	pathogens	_	_	NNS	_	_	_	_	_
11	use	_	_	VBP	_	_	_	_	_
12	several	_	_	JJ	_	_	_	_	_
13	virulence	_	_	NN	_	_	_	_	_
14	factors	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	which	_	_	WDT	_	_	_	_	_
17	are	_	_	VBP	_	_	_	_	_
18	involved	_	_	VBN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	different	_	_	JJ	_	_	_	_	_
22	steps	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	pathogenesis	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Of	_	_	IN	_	_	_	_	_
2	major	_	_	JJ	_	_	_	_	_
3	importance	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	capsule	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	both	_	_	CC	_	_	_	_	_
9	gram-positive	_	_	JJ	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	gram-negative	_	_	JJ	_	_	_	_	_
12	bacteria	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	capsular	_	_	JJ	_	_	_	_	_
3	polysaccharide	_	_	NN	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	protective	_	_	JJ	_	_	_	_	_
7	function	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	bloodstream	_	_	NN	_	_	_	_	_
10	survival	_	_	NN	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	was	_	_	VBD	_	_	_	_	_
5	observed	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	attenuate	_	_	VB	_	_	_	_	_
8	invasion	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	BBB	_	_	NNP	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	BCSFB	_	_	NNP	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	could	_	_	MD	_	_	_	_	_
3	result	_	_	VB	_	_	_	_	_
4	from	_	_	IN	_	_	_	_	_
5	electrostatic	_	_	JJ	_	_	_	_	_
6	repulsion	_	_	NN	_	_	_	_	_
7	or	_	_	CC	_	_	_	_	_
8	from	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	masking	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	bacterial	_	_	JJ	_	_	_	_	_
13	surface	_	_	NN	_	_	_	_	_
14	structures	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	necessity	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	capsule	_	_	NN	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	pathogens	_	_	NNS	_	_	_	_	_
9	survival	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	blood	_	_	NN	_	_	_	_	_
13	but	_	_	CC	_	_	_	_	_
14	simultaneous	_	_	JJ	_	_	_	_	_
15	hindrance	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	invasion	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	host	_	_	NN	_	_	_	_	_
21	’s	_	_	POS	_	_	_	_	_
22	tissues	_	_	NNS	_	_	_	_	_
23	indicates	_	_	VBZ	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	need	_	_	NN	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	regulation	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	capsule	_	_	NN	_	_	_	_	_
31	expression	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Besides	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	capsule	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	multitude	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	further	_	_	JJR	_	_	_	_	_
9	virulence	_	_	NN	_	_	_	_	_
10	factors	_	_	NNS	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	used	_	_	VBN	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	gram-positive	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	gram-negative	_	_	JJ	_	_	_	_	_
17	bacteria	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	include	_	_	VBP	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	among	_	_	IN	_	_	_	_	_
5	others	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	adhesins	_	_	NNS	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	internalins	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	pore-forming	_	_	VBG	_	_	_	_	_
12	toxins	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	factors	_	_	NNS	_	_	_	_	_
16	involved	_	_	VBN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	intracellular	_	_	JJ	_	_	_	_	_
19	movement	_	_	NN	_	_	_	_	_
20	as	_	_	RB	_	_	_	_	_
21	well	_	_	RB	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	cell-to	_	_	NN	_	_	_	_	_
24	cell	_	_	NN	_	_	_	_	_
25	spread	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	summarized	_	_	VBN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	Figure	_	_	NN	_	_	_	_	_
31	2	_	_	CD	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	review	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	will	_	_	MD	_	_	_	_	_
7	focus	_	_	VB	_	_	_	_	_
8	particularly	_	_	RB	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	virulence	_	_	NN	_	_	_	_	_
11	factors	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	evidence	_	_	NN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	an	_	_	DT	_	_	_	_	_
18	involvement	_	_	NN	_	_	_	_	_
19	during	_	_	IN	_	_	_	_	_
20	brain	_	_	NN	_	_	_	_	_
21	entry	_	_	NN	_	_	_	_	_
22	across	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	blood	_	_	NN	_	_	_	_	_
25	–	_	_	:	_	_	_	_	_
26	brain	_	_	NN	_	_	_	_	_
27	barriers	_	_	NNS	_	_	_	_	_
28	has	_	_	VBZ	_	_	_	_	_
29	been	_	_	VBN	_	_	_	_	_
30	proposed	_	_	VBN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	summary	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	virulence	_	_	NN	_	_	_	_	_
6	factors	_	_	NNS	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	gram-positive	_	_	JJ	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	gram-negative	_	_	JJ	_	_	_	_	_
11	bacteria	_	_	NN	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	given	_	_	VBN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	Table	_	_	NNP	_	_	_	_	_
16	1	_	_	CD	_	_	_	_	_
17	at	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	end	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	this	_	_	DT	_	_	_	_	_
22	section	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	4.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Gram-Positive	_	_	JJ	_	_	_	_	_
2	Bacteria	_	_	NN	_	_	_	_	_


1	4.1.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Listeria	_	_	NNP	_	_	_	_	_
2	Monocytogenes	_	_	NNP	_	_	_	_	_


1	Listeria	_	_	NNP	_	_	_	_	_
2	monocytogenes	_	_	NNS	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	L.	_	_	NNP	_	_	_	_	_
5	monocytogenes	_	_	NNS	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	facultative	_	_	JJ	_	_	_	_	_
10	intracellular	_	_	JJ	_	_	_	_	_
11	gram-positive	_	_	JJ	_	_	_	_	_
12	bacterium	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	traverse	_	_	VB	_	_	_	_	_
4	several	_	_	JJ	_	_	_	_	_
5	physiological	_	_	JJ	_	_	_	_	_
6	barriers	_	_	NNS	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	finally	_	_	RB	_	_	_	_	_
9	enter	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	brain	_	_	NN	_	_	_	_	_
12	via	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	BBB	_	_	NN	_	_	_	_	_
15	or	_	_	CC	_	_	_	_	_
16	BCSFB	_	_	NNP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	especially	_	_	RB	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	immunocompromised	_	_	JJ	_	_	_	_	_
21	individuals	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	ingested	_	_	VBN	_	_	_	_	_
4	through	_	_	IN	_	_	_	_	_
5	highly	_	_	RB	_	_	_	_	_
6	contaminated	_	_	VBN	_	_	_	_	_
7	food	_	_	NN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	host	_	_	NN	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	Once	_	_	RB	_	_	_	_	_
2	ingested	_	_	VBN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	L.	_	_	NNP	_	_	_	_	_
5	monocytogenes	_	_	NN	_	_	_	_	_
6	traverses	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	intestinal	_	_	JJ	_	_	_	_	_
9	epithelial	_	_	JJ	_	_	_	_	_
10	barrier	_	_	NN	_	_	_	_	_
11	into	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	lamina	_	_	NN	_	_	_	_	_
14	propria	_	_	NN	_	_	_	_	_
15	followed	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	dissemination	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	pathogen	_	_	NN	_	_	_	_	_
21	via	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	lymph	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	blood	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	L.	_	_	NNP	_	_	_	_	_
2	monocytogenes	_	_	NN	_	_	_	_	_
3	has	_	_	VBZ	_	_	_	_	_
4	multiple	_	_	JJ	_	_	_	_	_
5	target	_	_	NN	_	_	_	_	_
6	organs	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	including	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	liver	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	spleen	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	can	_	_	MD	_	_	_	_	_
16	enter	_	_	VB	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	CNS	_	_	NNP	_	_	_	_	_
19	across	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	barriers	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	brain	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	direct	_	_	JJ	_	_	_	_	_
5	traversal	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	BBB	_	_	NNP	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	BCSFB	_	_	NNP	_	_	_	_	_
11	via	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	transcellular	_	_	JJ	_	_	_	_	_
14	route	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	transportation	_	_	NN	_	_	_	_	_
17	across	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	BBB	_	_	NN	_	_	_	_	_
20	within	_	_	IN	_	_	_	_	_
21	leukocytes	_	_	NNS	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	retrograde	_	_	JJ	_	_	_	_	_
24	migration	_	_	NN	_	_	_	_	_
25	within	_	_	IN	_	_	_	_	_
26	axons	_	_	NNS	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	cranial	_	_	JJ	_	_	_	_	_
29	nerves	_	_	NNS	_	_	_	_	_
30	have	_	_	VBP	_	_	_	_	_
31	been	_	_	VBN	_	_	_	_	_
32	described	_	_	VBN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	L.	_	_	NNP	_	_	_	_	_
2	monocytogenes	_	_	NN	_	_	_	_	_
3	can	_	_	MD	_	_	_	_	_
4	enter	_	_	VB	_	_	_	_	_
5	non-phagocytotic	_	_	JJ	_	_	_	_	_
6	cells	_	_	NNS	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	hijacking	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	host	_	_	NN	_	_	_	_	_
11	’s	_	_	POS	_	_	_	_	_
12	receptor-mediated	_	_	JJ	_	_	_	_	_
13	endocytosis	_	_	NN	_	_	_	_	_
14	machinery	_	_	NN	_	_	_	_	_
15	using	_	_	VBG	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	zipper	_	_	NN	_	_	_	_	_
18	mechanism	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	two	_	_	CD	_	_	_	_	_
3	major	_	_	JJ	_	_	_	_	_
4	invasion	_	_	NN	_	_	_	_	_
5	proteins	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	L.	_	_	NNP	_	_	_	_	_
8	monocytogenes	_	_	NNS	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	internalin	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	InlA	_	_	NNP	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	InlB	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	bind	_	_	VBP	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	eukaryotic	_	_	JJ	_	_	_	_	_
21	cell	_	_	NN	_	_	_	_	_
22	membrane	_	_	NN	_	_	_	_	_
23	members	_	_	NNS	_	_	_	_	_
24	E-cadherin	_	_	NNP	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	tyrosine	_	_	NN	_	_	_	_	_
27	kinase	_	_	NN	_	_	_	_	_
28	receptor	_	_	NN	_	_	_	_	_
29	protein	_	_	NN	_	_	_	_	_
30	Met	_	_	NNP	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	respectively	_	_	RB	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	interactions	_	_	NNS	_	_	_	_	_
3	induce	_	_	VBP	_	_	_	_	_
4	receptor-mediated	_	_	JJ	_	_	_	_	_
5	endocytosis	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	pathogen	_	_	NN	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	L.	_	_	NNP	_	_	_	_	_
2	monocytogenes	_	_	NNP	_	_	_	_	_
3	has	_	_	VBZ	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	demonstrated	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	use	_	_	VB	_	_	_	_	_
8	one	_	_	CD	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	both	_	_	DT	_	_	_	_	_
11	internalins	_	_	NNS	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	mediate	_	_	VB	_	_	_	_	_
14	invasion	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	BBB	_	_	NNP	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	BCSFB	_	_	NNP	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	further	_	_	RBR	_	_	_	_	_
6	demonstrated	_	_	VBN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	importance	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	bacterial	_	_	JJ	_	_	_	_	_
12	surface	_	_	NN	_	_	_	_	_
13	protein	_	_	NN	_	_	_	_	_
14	InlF	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	showing	_	_	VBG	_	_	_	_	_
17	that	_	_	IN	_	_	_	_	_
18	interaction	_	_	NN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	surface	_	_	NN	_	_	_	_	_
21	vimentin	_	_	NN	_	_	_	_	_
22	was	_	_	VBD	_	_	_	_	_
23	required	_	_	VBN	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	an	_	_	DT	_	_	_	_	_
26	optimal	_	_	JJ	_	_	_	_	_
27	colonialization	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	brain	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	MAPK	_	_	NNP	_	_	_	_	_
3	signaling	_	_	VBG	_	_	_	_	_
4	cascade	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	activated	_	_	VBN	_	_	_	_	_
7	during	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	invasion	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	L.	_	_	NNP	_	_	_	_	_
12	monocytogenes	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	model	_	_	NN	_	_	_	_	_
4	system	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	BCSFB	_	_	NN	_	_	_	_	_
8	consisting	_	_	VBG	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	choroid	_	_	JJ	_	_	_	_	_
11	plexus	_	_	NN	_	_	_	_	_
12	epithelial	_	_	JJ	_	_	_	_	_
13	cells	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	requirement	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	MAPK	_	_	NNP	_	_	_	_	_
19	activation	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	listerial	_	_	JJ	_	_	_	_	_
22	entry	_	_	NN	_	_	_	_	_
23	was	_	_	VBD	_	_	_	_	_
24	demonstrated	_	_	VBN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Both	_	_	DT	_	_	_	_	_
2	extracellular	_	_	JJ	_	_	_	_	_
3	signal-regulated	_	_	VBN	_	_	_	_	_
4	kinases	_	_	NNS	_	_	_	_	_
5	(	_	_	-LRB-	_	_	_	_	_
6	ERK	_	_	NN	_	_	_	_	_
7	)	_	_	-RRB-	_	_	_	_	_
8	1	_	_	CD	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	2	_	_	CD	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	p38	_	_	NN	_	_	_	_	_
13	inhibition	_	_	NN	_	_	_	_	_
14	resulted	_	_	VBD	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	decreased	_	_	VBN	_	_	_	_	_
17	bacterial	_	_	JJ	_	_	_	_	_
18	invasion	_	_	NN	_	_	_	_	_
19	into	_	_	IN	_	_	_	_	_
20	this	_	_	DT	_	_	_	_	_
21	model	_	_	NN	_	_	_	_	_
22	system	_	_	NN	_	_	_	_	_
23	suggesting	_	_	VBG	_	_	_	_	_
24	their	_	_	PRP$	_	_	_	_	_
25	involvement	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	pathogens	_	_	NNS	_	_	_	_	_
29	traversal	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	BCSFB	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	previously	_	_	RB	_	_	_	_	_
4	described	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	ubiquitination	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	E-cadherin	_	_	NNP	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	Met	_	_	NNP	_	_	_	_	_
11	leads	_	_	VBZ	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	recruitment	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	clathrin-mediated	_	_	JJ	_	_	_	_	_
18	endocytosis	_	_	NN	_	_	_	_	_
19	machinery	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	turn	_	_	NN	_	_	_	_	_
4	results	_	_	VBZ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	polymerization	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	actin	_	_	NN	_	_	_	_	_
11	cytoskeleton	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	During	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	process	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	dynamin	_	_	NN	_	_	_	_	_
6	recruits	_	_	VBZ	_	_	_	_	_
7	several	_	_	JJ	_	_	_	_	_
8	factors	_	_	NNS	_	_	_	_	_
9	that	_	_	WDT	_	_	_	_	_
10	result	_	_	VBP	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	two	_	_	CD	_	_	_	_	_
13	waves	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	actin	_	_	NN	_	_	_	_	_
16	rearrangements	_	_	NNS	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	subsequently	_	_	RB	_	_	_	_	_
19	result	_	_	VBP	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	entry	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	pathogen	_	_	NN	_	_	_	_	_
26	inside	_	_	IN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	vacuoles	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Accordingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	an	_	_	DT	_	_	_	_	_
4	in	_	_	FW	_	_	_	_	_
5	vitro	_	_	NN	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	using	_	_	VBG	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	model	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	BCSFB	_	_	NNP	_	_	_	_	_
13	based	_	_	VBN	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	HIBCPP	_	_	NNP	_	_	_	_	_
16	cells	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	revealed	_	_	VBD	_	_	_	_	_
19	that	_	_	IN	_	_	_	_	_
20	L.	_	_	NNP	_	_	_	_	_
21	monocytogenes	_	_	NN	_	_	_	_	_
22	invasion	_	_	NN	_	_	_	_	_
23	is	_	_	VBZ	_	_	_	_	_
24	inhibited	_	_	VBN	_	_	_	_	_
25	if	_	_	IN	_	_	_	_	_
26	dynamin-mediated	_	_	JJ	_	_	_	_	_
27	endocytosis	_	_	NN	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	blocked	_	_	VBN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	essential	_	_	JJ	_	_	_	_	_
3	virulence	_	_	NN	_	_	_	_	_
4	factor	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	L.	_	_	NNP	_	_	_	_	_


1	monocytogenes	_	_	NN	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	pore-forming	_	_	JJ	_	_	_	_	_
5	cytolysin	_	_	NN	_	_	_	_	_
6	Listeriolysin	_	_	NNP	_	_	_	_	_
7	O	_	_	NNP	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	LLO	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	Activation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	NF-κB	_	_	NNP	_	_	_	_	_
5	signaling	_	_	NN	_	_	_	_	_
6	pathway	_	_	NN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	LLO	_	_	NNP	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	reported	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	human	_	_	JJ	_	_	_	_	_
14	embryonic	_	_	JJ	_	_	_	_	_
15	kidney	_	_	NN	_	_	_	_	_
16	HEK-293	_	_	NNP	_	_	_	_	_
17	cell	_	_	NN	_	_	_	_	_
18	line	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	as	_	_	RB	_	_	_	_	_
21	well	_	_	RB	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	MAPK	_	_	NNP	_	_	_	_	_
24	signaling	_	_	VBG	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	secreted	_	_	VBN	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	L.	_	_	NNP	_	_	_	_	_
6	monocytogenes	_	_	NNP	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	promotes	_	_	VBZ	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	pathogens	_	_	NNS	_	_	_	_	_
11	intracellular	_	_	JJ	_	_	_	_	_
12	survival	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	After	_	_	IN	_	_	_	_	_
2	entering	_	_	VBG	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	host	_	_	NN	_	_	_	_	_
5	cell	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	lysis	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	vacuole	_	_	NN	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	initiated	_	_	VBN	_	_	_	_	_
13	through	_	_	IN	_	_	_	_	_
14	LLO	_	_	NNP	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	bacterial	_	_	JJ	_	_	_	_	_
18	phospholipases	_	_	NNS	_	_	_	_	_
19	PlcA	_	_	NNP	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	PlcB	_	_	NNP	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	followed	_	_	VBN	_	_	_	_	_
25	by	_	_	IN	_	_	_	_	_
26	intracellular	_	_	JJ	_	_	_	_	_
27	spread	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	cytoplasm	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Once	_	_	RB	_	_	_	_	_
2	L.	_	_	NNP	_	_	_	_	_
3	monocytogenes	_	_	NN	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	reached	_	_	VBN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	cytoplasm	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	host´s	_	_	NNS	_	_	_	_	_
11	cells	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	it	_	_	PRP	_	_	_	_	_
14	has	_	_	VBZ	_	_	_	_	_
15	been	_	_	VBN	_	_	_	_	_
16	demonstrated	_	_	VBN	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	move	_	_	VB	_	_	_	_	_
19	around	_	_	RP	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	enter	_	_	VB	_	_	_	_	_
22	neighboring	_	_	VBG	_	_	_	_	_
23	cells	_	_	NNS	_	_	_	_	_
24	using	_	_	VBG	_	_	_	_	_
25	actin	_	_	NN	_	_	_	_	_
26	comet	_	_	NN	_	_	_	_	_
27	tails	_	_	NNS	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	membrane	_	_	NN	_	_	_	_	_
30	protrusions	_	_	NNS	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	facilitate	_	_	VB	_	_	_	_	_
33	its	_	_	PRP$	_	_	_	_	_
34	spread	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	F-actin-based	_	_	JJ	_	_	_	_	_
3	intracellular	_	_	JJ	_	_	_	_	_
4	motility	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	dependent	_	_	VBN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	expression	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	another	_	_	DT	_	_	_	_	_
12	essential	_	_	JJ	_	_	_	_	_
13	listerial	_	_	JJ	_	_	_	_	_
14	virulence	_	_	NN	_	_	_	_	_
15	factor	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	ActA	_	_	NNP	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Activation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	NF-κB	_	_	NNP	_	_	_	_	_
5	signaling	_	_	NN	_	_	_	_	_
6	pathway	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	previously	_	_	RB	_	_	_	_	_
11	described	_	_	VBN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	achieved	_	_	VBN	_	_	_	_	_
14	through	_	_	IN	_	_	_	_	_
15	LLO	_	_	NNP	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	mechanism	_	_	NN	_	_	_	_	_
3	involving	_	_	VBG	_	_	_	_	_
4	NF-κB	_	_	NNP	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	its	_	_	PRP$	_	_	_	_	_
7	activation	_	_	NN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	InlC	_	_	NNP	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	secreted	_	_	VBN	_	_	_	_	_
14	intracellularly	_	_	RB	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	directly	_	_	RB	_	_	_	_	_
4	interact	_	_	VB	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	subunit	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	IκB	_	_	NNP	_	_	_	_	_
11	kinase	_	_	NN	_	_	_	_	_
12	complex	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	IKKα	_	_	NNP	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	By	_	_	IN	_	_	_	_	_
2	phosphorylating	_	_	VBG	_	_	_	_	_
3	IκB	_	_	NNP	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	this	_	_	DT	_	_	_	_	_
6	complex	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	critical	_	_	JJ	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	activation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	NF-κB	_	_	NNP	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	major	_	_	JJ	_	_	_	_	_
17	regulator	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	innate	_	_	JJ	_	_	_	_	_
20	immune	_	_	JJ	_	_	_	_	_
21	response	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	InlC	_	_	NNP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	shown	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	impair	_	_	VB	_	_	_	_	_
6	phosphorylation	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	IκB	_	_	NNP	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	thereby	_	_	RB	_	_	_	_	_
11	scaling	_	_	VBG	_	_	_	_	_
12	down	_	_	RP	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	hosts	_	_	NNS	_	_	_	_	_
15	immune	_	_	JJ	_	_	_	_	_
16	response	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	also	_	_	RB	_	_	_	_	_
21	involved	_	_	VBN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	cell-to-cell	_	_	JJ	_	_	_	_	_
24	spread	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_

